文献速递肝病消化道肿瘤与早癌

HBV整合重塑基因组结构促进肝细胞癌发生

HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
PubMed 文献 · Gut · 2024-06-06

该研究对124例不同年龄肝细胞癌(HCC)样本行全基因组测序和Nanopore长读长测序,系统解析HBV整合的基因组结构,发现整合介导的基因组重排富集于桥-融合-桥模式和染色体间易位,常导致驱动性拷贝数变异,尤以8q超早期扩增为著,并通过CRISPR筛选验证TONSL和TMEM65扩增的致瘤潜能。

要点

  • HBV整合介导的基因组重排显著富集桥-融合-桥模式和染色体间易位。
  • 整合相关重排常导致4q、5p(TERT)、6q、8p、16q、9p(CDKN2A/B)、17p(TP53)和13q(RB1)驱动拷贝数变异。
  • TONSL和TMEM65(8q)扩增由HBV整合驱动,并经CRISPR/Cas9编辑验证其致瘤潜能。

核心结论

  • HBV整合广泛重塑基因组结构并促进肝细胞癌发生,且可能发生在患者生命早期。

研究设计与样本

  • 对124例不同年龄的肝细胞癌样本行全基因组测序和Nanopore长读长测序,解析HBV整合的基因组结构。
  • 在小鼠肝细胞行CRISPR-based gain-of-function遗传筛选,并逐一激活小鼠模型中各候选基因。

主要发现

  • HBV介导的重排显著富集桥-融合-桥模式和染色体间易位,常导致驱动拷贝数变异,包括4q、5p(TERT)、6q、8p、16q、9p(CDKN2A/B)、17p(TP53)和13q(RB1),尤以8q超早期扩增为著。
  • 整合的HBV常含复杂结构,与易位距离相关;每个整合事件内配对断点通常呈现不同微同源性,可能由不同DNA修复机制介导。
  • HBV介导的重排与年轻年龄、较高HBV DNA水平和TP53突变显著相关,但在接受过抗病毒治疗的患者中较少见。
  • 通过CRISPR/Cas9编辑重现了HBV整合导致的chr8q上TONSL和TMEM65扩增,并证明其致瘤潜能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), mostly characterised by HBV integrations, is prevalent worldwide. Previous HBV studies mainly focused on a few hotspot integrations. However, the oncogenic role of the other HBV integrations remains unclear. This study aimed to elucidate HBV integration-induced tumourigenesis further. DESIGN: Here, we illuminated the genomic structures encompassing HBV integrations in 124 HCCs across ages using whole genome sequencing and Nanopore long reads. We classified a repertoire of integration patterns featured by complex genomic rearrangement. We also conducted a clustered regularly interspaced short palindromic repeat (CRISPR)-based gain-of-function genetic screen in mouse hepatocytes. We individually activated each candidate gene in the mouse model to uncover HBV integration-mediated oncogenic aberration that elicits tumourigenesis in mice. RESULTS: These HBV-mediated rearrangements are significantly enriched in a bridge-fusion-bridge pattern and interchromosomal translocations, and frequently led to a wide range of aberrations including driver copy number variations in chr 4q, 5p (TERT), 6q, 8p, 16q, 9p (CDKN2A/B), 17p (TP53) and 13q (RB1), and particularly, ultra-early amplifications in chr8q. Integrated HBV frequently contains complex structures correlated with the translocation distance. Paired breakpoints within each integration event usually exhibit different microhomology, likely mediated by different DNA repair mechanisms. HBV-mediated rearrangements significantly correlated with young age, higher HBV DNA level and TP53 mutations but were less prevalent in the patients subjected to prior antiviral therapies. Finally, we recapitulated the TONSL and TMEM65 amplification in chr8q led by HBV integration using CRISPR/Cas9 editing and demonstrated their tumourigenic potentials. CONCLUSION: HBV integrations extensively reshape genomic structures and promote hepatocarcinogenesis (graphical abstract), which may occur early in a patient's life.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Qian Z, Liang J, Huang R, et al. HBV integrations reshaping genomic structures promote hepatocellular carcinoma. Gut. 2024. PMID: 38395437. doi:10.1136/gutjnl-2023-330414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。